| 摘要 |
<p>The present invention relates to novel salt forms forms of tegaserod, their crystalline forms and their use in pharmaceutical compositions useful in the treatment of irritable bowel syndrome, gastro-esophageal reflux disease, functional dyspepsia, chronic constipation or diarrhea, and their production.</p> |
